Nurix Therapeutics Inc Financial Flexibility Index
Nurix Therapeutics Inc financial flexibility index. Nurix Therapeutics Inc (NRIX) has a Financial Flexibility Index of -0.36x as of August 2025. Free cash flow of $-54.67 Million (operating CF $-57.38 Million minus capex $2.71 Million) represents 0% of total liabilities ($150.22 Million). Explore NRIX capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Nurix Therapeutics Inc (2018–2024)
Financial flexibility index of Nurix Therapeutics Inc from 2018 to 2024. Historical Financial Flexibility Index trend for Nurix Therapeutics Inc across 7 annual periods. Check Nurix Therapeutics Inc (NRIX) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Nurix Therapeutics Inc Financial Flexibility Index by Year (2018–2024)
Nurix Therapeutics Inc financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for Nurix Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Nurix Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.15x | $-163.31 Million | $-172.58 Million | $142.35 Million | ▼ -143.9% |
| 2023 | -0.47x | $-72.96 Million | $-81.36 Million | $155.10 Million | ▲ +64.0% |
| 2022 | -1.31x | $-147.56 Million | $-159.81 Million | $113.06 Million | ▼ -123.0% |
| 2021 | -0.59x | $-78.70 Million | $-84.36 Million | $134.47 Million | ▼ -1488.0% |
| 2020 | 0.04x | $4.47 Million | $-80.00K | $106.07 Million | ▲ +0.3% |
| 2019 | 0.04x | $2.25 Million | $601.00K | $53.57 Million | ▲ +104.8% |
| 2018 | -0.88x | $-30.08 Million | $-31.68 Million | $34.05 Million | — |